Carsten Brunn | President & Chief Executive Officer |
Kevin Tan | Chief Financial Officer |
Peter Traber | Chief Medical Officer |
Kei Kishimoto | Chief Scientific Officer |
John Newman | Canaccord |
Kristen Kluska | Cantor Fitzgerald |
Yun Zhong | BTIG |
Raju Prasad | William Blair |
Uy Ear | Mizuho |
Boobalan Pachaiyappan | HC Wainwright |
Chang Liu | Needham |
00:05 Good morning and welcome to the Selecta Biosciences First Quarter 2022 Financial Results and Corporate Update Conference Call. Currently, all participants are in a listen-only mode. This call is being webcast live on the Investors and Media section of Selecta's website at www.selectabio.com, and it is being recorded. 00:27 For opening remarks, I would like to introduce Kevin Tan, Chief Financial Officer of Selecta. Please go ahead.